| Views | |
|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 322 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations | 17 | 5 | 10 | 17 | 21 | 2 | 16 |
| Views | |
|---|---|
| 1-s2.0-S2211124721008500-main.pdf | 328 |
